122 related articles for article (PubMed ID: 33993805)
1. Gastric cancer detection using the serum pepsinogen test method.
Trivanovic D; Plestina S; Honovic L; Dobrila-Dintinjana R; Vlasic Tanaskovic J; Vrbanec D
Tumori; 2022 Aug; 108(4):386-391. PubMed ID: 33993805
[TBL] [Abstract][Full Text] [Related]
2. Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study.
Shikata K; Ninomiya T; Yonemoto K; Ikeda F; Hata J; Doi Y; Fukuhara M; Matsumoto T; Iida M; Kitazono T; Kiyohara Y
Scand J Gastroenterol; 2012 Jun; 47(6):669-75. PubMed ID: 22428879
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer screening using the serum pepsinogen test method.
Miki K
Gastric Cancer; 2006; 9(4):245-53. PubMed ID: 17235625
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.
Wang Y; Zhu Z; Liu Z; Zhao Z; Xue X; Li X; Li P; Rong G; Ma Y
J Int Med Res; 2020 Mar; 48(3):300060520914826. PubMed ID: 32228342
[TBL] [Abstract][Full Text] [Related]
6. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
8. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening.
Dinis-Ribeiro M; Yamaki G; Miki K; Costa-Pereira A; Matsukawa M; Kurihara M
J Med Screen; 2004; 11(3):141-7. PubMed ID: 15333273
[TBL] [Abstract][Full Text] [Related]
10. Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.
Begum A; Baten MA; Begum Z; Ahsan MM; Rahman SF; Chowdhury F; Khan AH
Mymensingh Med J; 2017 Jul; 26(3):628-634. PubMed ID: 28919620
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
Gong YH; Sun LP; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
13. Serum pepsinogen test for early detection of gastric cancer in a European country.
Lomba-Viana R; Dinis-Ribeiro M; Fonseca F; Vieira AS; Bento MJ; Lomba-Viana H
Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):37-41. PubMed ID: 21989121
[TBL] [Abstract][Full Text] [Related]
14. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
[TBL] [Abstract][Full Text] [Related]
15. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
[TBL] [Abstract][Full Text] [Related]
16. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
[TBL] [Abstract][Full Text] [Related]
17. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
18. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer.
Han XL; Yi CL; Ma JD; He Y; Wu LM; Wang YF; Yang HJ; Liang DY; Shi JF
Lab Med; 2022 Jan; 53(1):71-77. PubMed ID: 34508270
[TBL] [Abstract][Full Text] [Related]
20. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.
Kaise M; Miwa J; Tashiro J; Ohmoto Y; Morimoto S; Kato M; Urashima M; Ikegami M; Tajiri H
J Gastroenterol; 2011 Jun; 46(6):736-45. PubMed ID: 21455714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
